Comparing with effects of the single or dual PPAR agonists, Lanifibranor, PPAR pan-agonist, improves all histological features of steatohepatitis in mice model of NASH, including liver fibrosis60, 117, 118. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.